Literature DB >> 12411834

Could automated template based quantification of benzodiazepine receptors in brain single photon emission tomography with 123I NNC 13-8241 be used to demonstrate neuronal damage in traumatic brain injury?

T Kauppinen1, A Ahonen, V Tuomivaara, J Hiltunen, K Bergstrom, J Kuikka, P Torniainen, M Hillbom.   

Abstract

Automated methods are required for the analysis of brain single photon emission tomography images. We applied an automated method to assess the benzodiazepine receptor distribution in the brain. Images of 19 patients with mild traumatic brain injury who had received I NNC 13-8241 were compared with a mean brain template accumulated from 18 healthy volunteers. To obtain more information, we calculated the neuronal benzodiazepine receptor binding in the brain by using pre-defined anatomical regions and a voxel-by-voxel technique. The group of patients with mild traumatic brain injury differed significantly (P =0.015) from the group of healthy volunteers in the distribution of benzodiazepine receptors. This methodological work suggests that a reference based template and a three-dimensional brain model help in regional analysis and quantification and could be useful in demonstrating permanent neuronal damage after head injury.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12411834     DOI: 10.1097/00006231-200211000-00005

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  2 in total

Review 1.  Weaving single photon imaging into new drug development.

Authors:  P David Mozley
Journal:  Mol Imaging Biol       Date:  2005 Jan-Feb       Impact factor: 3.488

Review 2.  Clinical utility of SPECT neuroimaging in the diagnosis and treatment of traumatic brain injury: a systematic review.

Authors:  Cyrus A Raji; Robert Tarzwell; Dan Pavel; Howard Schneider; Michael Uszler; John Thornton; Muriel van Lierop; Phil Cohen; Daniel G Amen; Theodore Henderson
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.